ONTOLOGY REPORT - ANNOTATIONS
| Term: | organic hydride |
|
| Accession: | CHEBI:37175
|
browse the term
|
| Synonyms: | related_synonym: | organic hydrides |
|
|
bromomethane
|
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
chloromethane
|
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
dichloromethane
|
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
increases expression |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
increases expression |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
increases expression |
EXP |
11 |
49,690,402 |
49,856,762 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 molecule |
|
decreases expression |
EXP |
1 |
95,709,961 |
95,715,116 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases expression |
EXP |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
increases expression |
EXP |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
increases expression |
EXP |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
increases expression |
EXP |
10 |
5,087,174 |
5,133,418 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
increases expression |
ISO |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases mutagenesis |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
increases expression |
EXP |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
increases methylation |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dennd5a |
DENN/MADD domain containing 5A |
|
increases expression |
ISO |
1 |
167,519,644 |
167,586,964 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
increases expression |
ISO |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
increases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Evi2a |
ecotropic viral integration site 2A |
|
increases expression |
ISO |
10 |
65,713,406 |
65,717,306 |
RGD:6480464 |
CTD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
increases expression |
EXP |
2 |
191,095,026 |
191,103,942 |
RGD:6480464 |
CTD |
| G |
Filip1l |
filamin A interacting protein 1-like |
|
increases expression |
ISO |
11 |
43,788,676 |
43,859,932 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gp1bb |
glycoprotein Ib (platelet), beta polypeptide |
|
decreases expression |
EXP |
11 |
84,369,795 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
|
decreases expression |
EXP |
8 |
70,642,670 |
70,811,822 |
RGD:6480464 |
CTD |
| G |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
|
increases expression |
ISO |
1 |
8,783,016 |
9,032,351 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrpll |
heterogeneous nuclear ribonucleoprotein L-like |
|
increases expression |
ISO |
6 |
2,909,705 |
2,940,020 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
increases expression |
ISO |
1 |
238,559,729 |
238,565,793 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr2 |
interferon gamma receptor 2 |
|
increases expression |
ISO |
11 |
31,508,721 |
31,526,993 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il2rg |
interleukin 2 receptor, gamma |
|
increases expression |
EXP |
X |
89,342,055 |
89,345,715 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
decreases expression |
EXP |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Il9 |
interleukin 9 |
|
increases expression |
EXP |
17 |
14,068,757 |
14,071,880 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
increases expression |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Mxd1 |
max dimerization protein 1 |
|
increases expression |
ISO |
4 |
120,801,932 |
120,822,346 |
RGD:6480464 |
CTD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
decreases expression |
EXP |
8 |
52,822,350 |
53,120,572 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
increases expression |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
|
increases expression |
ISO |
17 |
29,304,750 |
29,354,613 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
increases expression |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
decreases expression |
EXP |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
increases expression |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
increases expression |
ISO |
14 |
101,870,272 |
101,924,228 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
decreases expression |
EXP |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases expression |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Ptger2 |
prostaglandin E receptor 2 (subtype EP2) |
|
increases expression |
ISO |
15 |
20,205,443 |
20,216,872 |
RGD:6480464 |
CTD |
| G |
Pvrl3 |
poliovirus receptor-related 3 |
|
decreases expression |
EXP |
11 |
55,843,801 |
55,940,634 |
RGD:6480464 |
CTD |
| G |
Rab8b |
RAB8B, member RAS oncogene family |
|
increases expression |
ISO |
8 |
71,156,502 |
71,231,807 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rnf149 |
ring finger protein 149 |
|
increases expression |
ISO |
9 |
38,623,812 |
38,647,344 |
RGD:6480464 |
CTD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
increases expression |
EXP |
20 |
4,697,971 |
4,702,564 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
increases expression |
EXP |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
RT1-DMb |
RT1 class II, locus DMb |
|
increases expression |
EXP |
20 |
4,829,535 |
4,836,772 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
increases expression |
EXP |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
increases expression |
ISO |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
increases expression |
ISO |
7 |
135,365,172 |
135,377,341 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Stx11 |
syntaxin 11 |
|
increases expression |
ISO |
1 |
7,683,757 |
7,685,378 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Trip12 |
thyroid hormone receptor interactor 12 |
|
decreases expression |
EXP |
9 |
83,961,411 |
84,085,077 |
RGD:6480464 |
CTD |
| G |
Usp18 |
ubiquitin specific peptidase 18 |
|
increases expression |
ISO |
4 |
157,692,720 |
157,694,884 |
RGD:6480464 |
CTD |
| G |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression |
EXP |
5 |
34,238,505 |
34,325,951 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases expression |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
|
increases expression |
ISO |
4 |
65,854,471 |
65,894,691 |
RGD:6480464 |
CTD |
| G |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
|
increases expression |
ISO |
13 |
12,148,072 |
12,196,570 |
RGD:6480464 |
CTD |
iodomethane
|
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases activity |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
decreases activity |
EXP |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases activity |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases alkylation |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
tetrachloromethane
|
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases expression |
EXP |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
decreases expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abce1 |
ATP-binding cassette, subfamily E (OABP), member 1 |
|
decreases expression |
ISO |
19 |
30,093,741 |
30,118,625 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abhd14a |
abhydrolase domain containing 14A |
|
decreases expression |
ISO |
8 |
111,583,674 |
111,591,234 |
RGD:6480464 |
CTD |
| G |
Abhd14b |
abhydrolase domain containing 14b |
|
affects expression |
ISO |
8 |
111,592,329 |
111,596,366 |
RGD:6480464 |
CTD |
| G |
Abi2 |
abl-interactor 2 |
|
decreases expression |
ISO |
9 |
59,028,651 |
59,079,887 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases phosphorylation |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
|
increases expression |
ISO |
3 |
88,858,336 |
89,012,166 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
decreases expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
EXP |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
decreases expression |
EXP |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
|
affects expression |
ISO |
8 |
109,124,763 |
109,190,186 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
affects expression |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
decreases expression |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
affects expression |
EXP |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
|
decreases expression |
ISO |
10 |
56,725,173 |
56,727,956 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases expression |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
affects expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
EXP |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
affects expression |
EXP |
14 |
80,769,000 |
80,809,809 |
RGD:6480464 |
CTD |
| G |
Acpl2 |
acid phosphatase-like 2 |
|
decreases expression |
ISO |
8 |
101,917,842 |
101,983,158 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
affects expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
decreases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
decreases expression |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
affects expression |
EXP |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
ISO |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
decreases expression |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
increases expression |
EXP |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
decreases expression |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
decreases expression |
EXP |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
increases expression |
ISO |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Aes |
amino-terminal enhancer of split |
|
decreases expression |
ISO |
7 |
9,616,545 |
9,621,697 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agfg2 |
ArfGAP with FG repeats 2 |
|
affects expression |
ISO |
12 |
19,716,015 |
19,752,171 |
RGD:6480464 |
CTD |
| G |
Agpat6 |
1-acylglycerol-3-phosphate O-acyltransferase 6 |
|
decreases expression |
EXP |
16 |
73,276,423 |
73,310,177 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
decreases expression |
ISO |
13 |
95,432,560 |
95,483,323 |
RGD:6480464 |
CTD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
increases expression |
ISO |
11 |
80,330,615 |
80,336,658 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
increases expression |
ISO |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
affects expression |
EXP |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
decreases expression |
EXP |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
increases expression |
EXP |
5 |
122,062,872 |
122,119,335 |
RGD:6480464 |
CTD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
increases expression |
ISO |
6 |
73,010,779 |
73,354,520 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
decreases expression |
ISO |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
affects expression |
ISO |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
decreases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
increases expression |
ISO |
5 |
62,311,268 |
62,316,276 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
decreases expression |
EXP |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alg14 |
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
|
decreases expression |
ISO |
2 |
217,875,370 |
217,970,049 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
affects expression |
EXP |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
decreases expression |
EXP |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
increases expression |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
affects expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
multiple interactions |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
decreases expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
increases expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
increases expression |
ISO |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
|
decreases expression |
ISO |
2 |
203,752,632 |
203,754,113 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin like 2 |
|
increases expression |
ISO |
8 |
107,694,405 |
107,709,841 |
RGD:6480464 |
CTD |
| G |
Amph |
amphiphysin |
|
affects expression |
EXP |
17 |
53,558,804 |
53,802,936 |
RGD:6480464 |
CTD |
| G |
Amy2a3 |
amylase 2a3 |
|
multiple interactions |
ISO |
2 |
209,507,212 |
209,518,455 |
RGD:6480464 |
CTD |
| G |
Angel2 |
angel homolog 2 (Drosophila) |
|
increases expression |
ISO |
13 |
107,013,927 |
107,030,231 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
decreases expression |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
increases expression |
EXP |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
decreases expression |
ISO |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
affects expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
decreases expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
increases expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
affects expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
affects localization |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
increases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
decreases expression |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Aqp5 |
aquaporin 5 |
|
decreases expression |
EXP |
7 |
138,337,725 |
138,341,257 |
RGD:6480464 |
CTD |
| G |
Aqp9 |
aquaporin 9 |
|
increases expression |
EXP |
8 |
75,611,485 |
75,651,646 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
affects expression |
EXP |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
increases expression |
EXP |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
decreases expression |
ISO |
18 |
30,893,720 |
30,916,965 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
decreases expression |
ISO |
18 |
30,893,720 |
30,916,965 |
RGD:6480464 |
CTD |
| G |
Arhgap1 |
Rho GTPase activating protein 1 |
|
increases expression |
ISO |
3 |
76,030,806 |
76,052,736 |
RGD:6480464 |
CTD |
| G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
increases expression |
ISO |
3 |
99,676,951 |
99,693,232 |
RGD:6480464 |
CTD |
| G |
Arhgap18 |
Rho GTPase activating protein 18 |
|
increases expression |
ISO |
1 |
18,967,836 |
19,116,268 |
RGD:6480464 |
CTD |
| G |
Arhgap28 |
Rho GTPase activating protein 28 |
|
decreases expression |
ISO |
9 |
106,996,258 |
107,162,388 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
decreases expression |
ISO |
X |
141,946,362 |
142,068,557 |
RGD:6480464 |
CTD |
| G |
Arl5a |
ADP-ribosylation factor-like 5A |
|
increases expression |
ISO |
3 |
33,905,755 |
33,926,681 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
affects expression |
EXP |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arsj |
arylsulfatase family, member J |
|
affects expression |
ISO |
2 |
223,574,825 |
223,666,259 |
RGD:6480464 |
CTD |
| G |
Art3 |
ADP-ribosyltransferase 3 |
|
decreases expression |
ISO |
14 |
17,198,267 |
17,280,642 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
decreases expression |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
increases expression |
ISO |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
decreases activity |
EXP |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
multiple interactions |
EXP |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
|
decreases expression |
ISO |
17 |
77,759,058 |
77,777,760 |
RGD:6480464 |
CTD |
| G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
|
decreases expression |
ISO |
4 |
30,150,502 |
30,188,132 |
RGD:6480464 |
CTD |
| G |
Asf1b |
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
|
increases expression |
ISO |
19 |
25,867,384 |
25,881,909 |
RGD:6480464 |
CTD |
| G |
Asgr1 |
asialoglycoprotein receptor 1 |
|
affects expression |
EXP |
10 |
56,899,266 |
56,903,173 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
decreases expression |
EXP |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
decreases expression |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
increases expression |
EXP |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
decreases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
increases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
decreases expression |
ISO |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
increases expression |
ISO |
9 |
70,676,744 |
70,696,865 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
increases expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
increases expression |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
decreases expression |
ISO |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Atp9a |
ATPase, class II, type 9A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
decreases expression |
EXP |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atrnl1 |
attractin like 1 |
|
decreases expression |
ISO |
1 |
263,919,358 |
264,486,579 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked |
|
affects expression |
ISO |
X |
93,903,794 |
94,051,337 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
multiple interactions |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
increases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
affects expression |
EXP |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
increases expression |
EXP |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
increases expression |
ISO |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
Bace2 |
beta-site APP-cleaving enzyme 2 |
|
decreases expression |
ISO |
11 |
37,345,568 |
37,428,155 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag2 |
Bcl2-associated athanogene 2 |
|
increases expression |
ISO |
9 |
32,491,167 |
32,493,678 |
RGD:6480464 |
CTD |
| G |
Baiap2 |
BAI1-associated protein 2 |
|
decreases expression |
ISO |
10 |
109,351,201 |
109,413,703 |
RGD:6480464 |
CTD |
| G |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
|
increases expression |
ISO |
12 |
10,584,749 |
10,668,948 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
multiple interactions |
EXP |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) |
|
decreases expression |
ISO |
17 |
62,654,385 |
62,658,641 |
RGD:6480464 |
CTD |
| G |
Banf1 |
barrier to autointegration factor 1 |
|
increases expression |
ISO |
1 |
208,008,344 |
208,010,342 |
RGD:6480464 |
CTD |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
increases expression |
ISO |
2 |
76,877,616 |
76,927,721 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcap29 |
B-cell receptor-associated protein 29 |
|
decreases expression |
ISO |
6 |
49,464,362 |
49,504,424 |
RGD:6480464 |
CTD |
| G |
Bcat1 |
branched chain amino acid transaminase 1, cytosolic |
|
increases expression |
ISO |
4 |
182,641,517 |
182,692,917 |
RGD:6480464 |
CTD |
| G |
Bckdha |
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
|
increases expression |
EXP |
1 |
80,837,906 |
80,866,672 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
decreases expression |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
multiple interactions |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
decreases expression |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
increases expression |
ISO |
11 |
71,130,561 |
71,165,695 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
increases expression |
ISO |
2 |
53,691,290 |
53,764,539 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
increases expression |
EXP |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Cachd1 |
cache domain containing 1 |
|
decreases expression |
ISO |
5 |
121,431,272 |
121,659,471 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
increases expression |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
|
increases expression |
ISO |
17 |
88,832,905 |
89,078,870 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
affects expression |
EXP |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
increases expression |
ISO |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cacng2 |
calcium channel, voltage-dependent, gamma subunit 2 |
|
decreases expression |
EXP |
7 |
115,913,440 |
116,037,891 |
RGD:6480464 |
CTD |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
affects expression |
ISO |
6 |
25,272,416 |
25,296,266 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
affects expression |
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Cadm3 |
cell adhesion molecule 3 |
|
affects expression |
ISO |
13 |
89,539,655 |
89,569,914 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
increases expression |
EXP |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
increases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
decreases expression |
ISO |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
|
decreases expression |
ISO |
4 |
149,220,661 |
149,229,168 |
RGD:6480464 |
CTD |
| G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
|
increases expression |
EXP |
4 |
149,220,661 |
149,229,168 |
RGD:6480464 |
CTD |
| G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
affects expression |
ISO |
5 |
157,235,534 |
157,237,314 |
RGD:6480464 |
CTD |
| G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
|
decreases expression |
ISO |
12 |
34,907,317 |
34,938,479 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
EXP |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
increases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
multiple interactions |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
affects expression |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
increases expression |
EXP |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
|
decreases expression |
ISO |
18 |
62,407,265 |
62,442,194 |
RGD:6480464 |
CTD |
| G |
Ccdc28a |
coiled-coil domain containing 28A |
|
increases expression |
ISO |
1 |
13,269,164 |
13,284,200 |
RGD:6480464 |
CTD |
| G |
Ccdc3 |
coiled-coil domain containing 3 |
|
decreases expression |
ISO |
17 |
84,115,413 |
84,219,015 |
RGD:6480464 |
CTD |
| G |
Ccdc39 |
coiled-coil domain containing 39 |
|
decreases expression |
ISO |
2 |
120,117,112 |
120,154,958 |
RGD:6480464 |
CTD |
| G |
Ccdc50 |
coiled-coil domain containing 50 |
|
affects expression |
ISO |
11 |
75,302,647 |
75,360,549 |
RGD:6480464 |
CTD |
| G |
Ccdc80 |
coiled-coil domain containing 80 |
|
affects expression |
ISO |
11 |
57,222,551 |
57,257,162 |
RGD:6480464 |
CTD |
| G |
Ccdc82 |
coiled-coil domain containing 82 |
|
affects expression |
ISO |
8 |
10,118,375 |
10,157,451 |
RGD:6480464 |
CTD |
| G |
Ccdc84 |
coiled-coil domain containing 84 |
|
decreases expression |
ISO |
8 |
47,376,648 |
47,383,464 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
increases expression |
ISO |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
|
increases expression |
ISO |
10 |
71,660,623 |
71,665,255 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
increases expression |
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
multiple interactions |
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
multiple interactions |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc5l |
cell division cycle 5-like |
|
decreases expression |
EXP |
9 |
11,165,631 |
11,204,135 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
increases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
increases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk11b |
cyclin-dependent kinase 11B |
|
affects expression |
EXP |
5 |
172,459,111 |
172,486,012 |
RGD:6480464 |
CTD |
| G |
Cdk14 |
cyclin-dependent kinase 14 |
|
affects expression |
ISO |
4 |
25,352,280 |
25,942,686 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
increases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
|
decreases expression |
ISO |
14 |
17,598,862 |
17,621,559 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
increases expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
increases expression |
ISO |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
|
decreases expression |
ISO |
10 |
105,460,482 |
105,472,167 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
affects expression |
ISO |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
EXP |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
increases expression |
ISO |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Cenpe |
centromere protein E |
|
increases expression |
ISO |
2 |
232,699,627 |
232,758,329 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
increases expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
affects expression |
ISO |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
affects expression |
ISO |
2 |
35,159,157 |
35,182,167 |
RGD:6480464 |
CTD |
| G |
Cenpn |
centromere protein N |
|
affects expression |
ISO |
19 |
47,029,240 |
47,051,557 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
affects expression |
ISO |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Cetn4 |
centrin 4 |
|
decreases expression |
ISO |
2 |
123,857,012 |
123,860,943 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
affects expression |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
affects expression |
EXP |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cgnl1 |
cingulin-like 1 |
|
increases expression |
ISO |
8 |
76,088,865 |
76,241,145 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
ISO |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Ch25h |
cholesterol 25-hydroxylase |
|
increases expression |
ISO |
1 |
238,457,017 |
238,458,335 |
RGD:6480464 |
CTD |
| G |
Chac1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
affects expression |
ISO |
3 |
105,869,762 |
105,873,332 |
RGD:6480464 |
CTD |
| G |
Chaf1b |
chromatin assembly factor 1, subunit B (p60) |
|
increases expression |
ISO |
11 |
34,110,848 |
34,130,928 |
RGD:6480464 |
CTD |
| G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
|
affects expression |
ISO |
20 |
13,124,662 |
13,126,461 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
increases expression |
EXP |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chfr |
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
46,651,265 |
46,684,689 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
multiple interactions |
ISO |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
increases expression |
ISO |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Chm |
choroideremia (Rab escort protein 1) |
|
increases expression |
EXP |
X |
101,753,857 |
101,927,941 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
decreases expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
increases expression |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
affects expression |
EXP |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrnb1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
|
increases expression |
ISO |
10 |
56,604,907 |
56,617,423 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
increases expression |
EXP |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
increases expression |
EXP |
16 |
69,028,625 |
69,069,274 |
RGD:6480464 |
CTD |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
affects expression |
EXP |
16 |
69,028,625 |
69,069,274 |
RGD:6480464 |
CTD |
| G |
Chst1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
decreases expression |
ISO |
3 |
76,994,089 |
77,008,874 |
RGD:6480464 |
CTD |
| G |
Chst11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
|
increases expression |
ISO |
7 |
22,721,892 |
22,950,084 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
increases expression |
ISO |
8 |
58,093,941 |
58,110,808 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
increases expression |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Ckap4 |
cytoskeleton-associated protein 4 |
|
increases expression |
ISO |
7 |
21,360,351 |
21,368,448 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases activity |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
|
increases expression |
ISO |
2 |
181,611,639 |
181,616,222 |
RGD:6480464 |
CTD |
| G |
Clca1 |
chloride channel accessory 1 |
|
increases expression |
ISO |
2 |
243,057,135 |
243,084,146 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
affects expression |
EXP |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel, voltage-sensitive 2 |
|
increases expression |
EXP |
11 |
82,427,792 |
82,441,293 |
RGD:6480464 |
CTD |
| G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
|
affects expression |
EXP |
16 |
32,447,259 |
32,518,533 |
RGD:6480464 |
CTD |
| G |
Clec11a |
C-type lectin domain family 11, member A |
|
increases expression |
ISO |
1 |
94,785,179 |
94,788,320 |
RGD:6480464 |
CTD |
| G |
Clec14a |
C-type lectin domain family 14, member A |
|
decreases expression |
ISO |
6 |
78,851,636 |
78,854,778 |
RGD:6480464 |
CTD |
| G |
Clic5 |
chloride intracellular channel 5 |
|
increases expression |
ISO |
9 |
12,370,341 |
12,472,969 |
RGD:6480464 |
CTD |
| G |
Cln3 |
ceroid-lipofuscinosis, neuronal 3 |
|
decreases expression |
ISO |
1 |
185,713,096 |
185,724,375 |
RGD:6480464 |
CTD |
| G |
Clspn |
claspin |
|
increases expression |
ISO |
5 |
145,930,764 |
145,965,672 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light chain B |
|
decreases expression |
EXP |
17 |
16,063,715 |
16,081,277 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col4a5 |
collagen, type IV, alpha 5 |
|
increases expression |
ISO |
X |
36,918,697 |
37,130,659 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
increases expression |
ISO |
3 |
6,826,169 |
6,971,054 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
increases expression |
EXP |
3 |
6,826,169 |
6,971,054 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
increases expression |
ISO |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
increases expression |
ISO |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
decreases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Coq3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
affects expression |
EXP |
5 |
36,640,718 |
36,656,981 |
RGD:6480464 |
CTD |
| G |
Cotl1 |
coactosin-like 1 (Dictyostelium) |
|
increases expression |
ISO |
19 |
50,096,620 |
50,130,253 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
decreases expression |
ISO |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
affects expression |
EXP |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cox6b2 |
cytochrome c oxidase subunit VIb polypeptide 2 |
|
increases expression |
ISO |
1 |
67,810,527 |
67,811,752 |
RGD:6480464 |
CTD |
| G |
Cox7a2 |
cytochrome c oxidase subunit VIIa polypeptide 2 |
|
affects expression |
EXP |
8 |
84,813,292 |
84,817,390 |
RGD:6480464 |
CTD |
| G |
Cox8a |
cytochrome c oxidase subunit VIIIa |
|
increases expression |
EXP |
1 |
209,886,141 |
209,888,462 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
affects expression |
ISO |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpq |
carboxypeptidase Q |
|
affects expression |
ISO |
7 |
68,430,069 |
68,900,500 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
increases expression |
ISO |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
increases expression |
ISO |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
multiple interactions |
EXP |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cpsf2 |
cleavage and polyadenylation specific factor 2, 100kDa |
|
decreases expression |
ISO |
6 |
126,246,237 |
126,274,144 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
affects expression |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
|
increases expression |
ISO |
3 |
76,361,149 |
76,401,633 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
increases expression |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
decreases expression |
ISO |
13 |
81,491,304 |
81,503,755 |
RGD:6480464 |
CTD |
| G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
|
affects expression |
ISO |
7 |
127,123,883 |
127,130,729 |
RGD:6480464 |
CTD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
affects expression |
EXP |
4 |
83,839,822 |
83,867,017 |
RGD:6480464 |
CTD |
| G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
|
increases expression |
ISO |
6 |
962,024 |
1,141,314 |
RGD:6480464 |
CTD |
| G |
Crip1 |
cysteine-rich protein 1 (intestinal) |
|
increases expression |
ISO |
6 |
138,156,366 |
138,161,127 |
RGD:6480464 |
CTD |
| G |
Crlf1 |
cytokine receptor-like factor 1 |
|
increases expression |
ISO |
16 |
19,431,472 |
19,442,747 |
RGD:6480464 |
CTD |
| G |
Cry1 |
cryptochrome 1 (photolyase-like) |
|
decreases expression |
ISO |
7 |
20,643,879 |
20,709,216 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Crybb3 |
crystallin, beta B3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
decreases expression |
ISO |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csnk1e |
casein kinase 1, epsilon |
|
decreases expression |
ISO |
7 |
117,402,718 |
117,420,764 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
increases expression |
ISO |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
decreases expression |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
increases expression |
EXP |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
increases expression |
ISO |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Ctbs |
chitobiase, di-N-acetyl- |
|
decreases expression |
ISO |
2 |
244,648,365 |
244,662,878 |
RGD:6480464 |
CTD |
| G |
Ctdp1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
|
decreases expression |
ISO |
18 |
77,304,752 |
77,365,895 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cthrc1 |
collagen triple helix repeat containing 1 |
|
increases expression |
ISO |
7 |
74,630,044 |
74,640,324 |
RGD:6480464 |
CTD |
| G |
Ctla2a |
cytotoxic T lymphocyte-associated protein 2 alpha |
|
increases expression |
ISO |
17 |
9,489,385 |
9,491,270 |
RGD:6480464 |
CTD |
| G |
Ctps |
CTP synthase |
|
increases expression |
ISO |
5 |
141,136,686 |
141,165,817 |
RGD:6480464 |
CTD |
| G |
Ctr9 |
Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
affects expression |
ISO |
1 |
168,784,355 |
168,814,971 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
decreases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsf |
cathepsin F |
|
increases expression |
ISO |
1 |
207,469,265 |
207,475,013 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
affects expression |
EXP |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
affects expression |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
increases expression |
ISO |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases expression |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases expression |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
|
decreases expression |
EXP |
1 |
245,298,381 |
245,339,035 |
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
decreases expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
increases expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
increases expression |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
|
increases expression |
EXP |
7 |
120,796,210 |
120,800,279 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases expression |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases expression |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases expression |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases degradation |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
|
decreases expression |
EXP |
5 |
116,744,337 |
116,766,822 |
RGD:6480464 |
CTD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
decreases expression |
ISO |
5 |
116,702,370 |
116,729,722 |
RGD:6480464 |
CTD |
| G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
12,926,125 |
13,002,576 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
decreases expression |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
affects expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
5 |
135,765,673 |
135,773,006 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
affects expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
|
affects expression |
EXP |
7 |
13,293,080 |
13,309,416 |
RGD:6480464 |
CTD |
| G |
Cyp4v3 |
cytochrome P450, family 4, subfamily v, polypeptide 3 |
|
decreases expression |
ISO |
16 |
50,208,687 |
50,233,625 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
affects expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dab2ip |
DAB2 interacting protein |
|
increases expression |
ISO |
3 |
14,667,700 |
14,840,625 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
affects expression |
EXP |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
affects expression |
ISO |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dagla |
diacylglycerol lipase, alpha |
|
affects expression |
ISO |
1 |
212,733,659 |
212,790,254 |
RGD:6480464 |
CTD |
| G |
Daxx |
death-domain associated protein |
|
increases expression |
ISO |
20 |
5,121,854 |
5,127,601 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dbp |
D site of albumin promoter (albumin D-box) binding protein |
|
multiple interactions |
ISO |
1 |
96,173,573 |
96,178,485 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
increases expression |
ISO |
11 |
42,941,795 |
42,980,245 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
increases expression |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dclk1 |
doublecortin-like kinase 1 |
|
increases expression |
ISO |
2 |
144,678,222 |
144,754,237 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
increases expression |
ISO |
1 |
78,449,324 |
78,450,578 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
decreases expression |
EXP |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
decreases expression |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Ect2 |
epithelial cell transforming sequence 2 oncogene |
|
increases expression |
ISO |
2 |
112,969,261 |
113,001,056 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
decreases expression |
EXP |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
decreases expression |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases activity |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
|
increases expression |
ISO |
17 |
32,217,424 |
32,228,130 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
decreases expression |
ISO |
14 |
109,733,625 |
109,828,630 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
decreases expression |
EXP |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efna5 |
ephrin A5 |
|
affects expression |
EXP |
9 |
101,227,615 |
101,532,696 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
increases expression |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
decreases expression |
ISO |
6 |
21,638,705 |
21,686,023 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
|
decreases expression |
ISO |
4 |
134,470,883 |
134,514,084 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
decreases expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
multiple interactions |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Elmo2 |
engulfment and cell motility 2 |
|
increases expression |
ISO |
3 |
156,328,613 |
156,366,106 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
multiple interactions |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
decreases expression |
EXP |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Enah |
enabled homolog (Drosophila) |
|
increases expression |
ISO |
13 |
97,919,690 |
98,025,153 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eng |
endoglin |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
decreases expression |
ISO |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
increases expression |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
increases expression |
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases activity |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase 5 |
|
decreases expression |
ISO |
9 |
12,574,480 |
12,581,130 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
increases expression |
EXP |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
|
decreases expression |
ISO |
3 |
146,876,451 |
146,944,603 |
RGD:6480464 |
CTD |
| G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
|
decreases expression |
ISO |
1 |
20,343,833 |
20,519,742 |
RGD:6480464 |
CTD |
| G |
Epdr1 |
ependymin related protein 1 (zebrafish) |
|
increases expression |
ISO |
17 |
53,135,000 |
53,160,954 |
RGD:6480464 |
CTD |
| G |
Epha3 |
Eph receptor A3 |
|
affects expression |
ISO |
11 |
696,185 |
1,033,287 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
decreases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
affects expression |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
increases expression |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Epm2aip1 |
EPM2A (laforin) interacting protein 1 |
|
increases expression |
ISO |
8 |
115,653,794 |
115,656,867 |
RGD:6480464 |
CTD |
| G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
decreases expression |
ISO |
4 |
174,601,291 |
174,672,247 |
RGD:6480464 |
CTD |
| G |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
|
affects expression |
ISO |
2 |
1,453,878 |
1,492,671 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
increases expression |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Ercc8 |
excision repair cross-complementing rodent repair deficiency, complementation group 8 |
|
decreases expression |
ISO |
2 |
39,382,976 |
39,420,764 |
RGD:6480464 |
CTD |
| G |
Eri1 |
exoribonuclease 1 |
|
affects expression |
ISO |
16 |
60,422,764 |
60,442,317 |
RGD:6480464 |
CTD |
| G |
Esam |
endothelial cell adhesion molecule |
|
decreases expression |
ISO |
8 |
38,773,224 |
38,784,349 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D |
|
affects expression |
ISO |
15 |
55,556,681 |
55,576,172 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
decreases expression |
ISO |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
decreases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Exd1 |
exonuclease 3'-5' domain containing 1 |
|
affects expression |
ISO |
3 |
106,038,460 |
106,066,302 |
RGD:6480464 |
CTD |
| G |
Exo1 |
exonuclease 1 |
|
increases expression |
ISO |
13 |
91,619,024 |
91,644,366 |
RGD:6480464 |
CTD |
| G |
Exoc4 |
exocyst complex component 4 |
|
affects expression |
ISO |
4 |
60,406,942 |
61,284,294 |
RGD:6480464 |
CTD |
| G |
Exosc8 |
exosome component 8 |
|
decreases expression |
ISO |
2 |
143,954,943 |
143,961,239 |
RGD:6480464 |
CTD |
| G |
Ezh1 |
enhancer of zeste homolog 1 (Drosophila) |
|
decreases expression |
ISO |
10 |
90,211,249 |
90,237,563 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
increases expression |
ISO |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
affects expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
decreases expression |
ISO |
13 |
87,369,918 |
87,393,508 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases activity |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
multiple interactions |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
decreases expression |
ISO |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
increases expression |
ISO |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
increases expression |
EXP |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
affects expression |
EXP |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
|
affects expression |
EXP |
11 |
86,700,118 |
86,767,928 |
RGD:6480464 |
CTD |
| G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
|
increases expression |
ISO |
7 |
31,160,021 |
31,286,379 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases expression |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects response to substance |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
decreases expression |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
increases expression |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
decreases expression |
ISO |
11 |
74,208,696 |
74,481,037 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
affects response to substance |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
increases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
increases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
increases expression |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
increases expression |
EXP |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
EXP |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
decreases expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
decreases response to substance |
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
increases expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
affects expression |
EXP |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
increases expression |
EXP |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
increases expression |
EXP |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
increases expression |
ISO |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Ficd |
FIC domain containing |
|
increases expression |
ISO |
12 |
43,924,661 |
43,927,515 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
affects expression |
EXP |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
increases expression |
ISO |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Fignl1 |
fidgetin-like 1 |
|
increases expression |
ISO |
14 |
92,685,445 |
92,693,967 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
increases expression |
ISO |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fkbp1a |
FK506 binding protein 1a |
|
increases expression |
EXP |
3 |
141,861,237 |
141,880,797 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
ISO |
4 |
165,448,027 |
165,456,481 |
RGD:6480464 |
CTD |
| G |
Fkbp7 |
FK506 binding protein 7 |
|
increases expression |
ISO |
3 |
59,361,703 |
59,373,382 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin B, beta |
|
increases expression |
ISO |
15 |
18,949,027 |
19,082,504 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
increases expression |
ISO |
4 |
56,313,707 |
56,341,400 |
RGD:6480464 |
CTD |
| G |
Flt4 |
fms-related tyrosine kinase 4 |
|
increases expression |
EXP |
10 |
35,071,002 |
35,112,006 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
affects expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
affects expression |
EXP |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fmod |
fibromodulin |
|
increases expression |
ISO |
13 |
46,987,714 |
46,998,331 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
affects expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
affects expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fnbp4 |
formin binding protein 4 |
|
decreases expression |
EXP |
3 |
75,111,004 |
75,141,649 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
affects expression |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
EXP |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxp1 |
forkhead box P1 |
|
affects expression |
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
increases expression |
ISO |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Fry |
furry homolog (Drosophila) |
|
affects expression |
ISO |
12 |
4,886,882 |
5,135,963 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
increases expression |
EXP |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Fstl3 |
follistatin-like 3 (secreted glycoprotein) |
|
affects expression |
ISO |
7 |
11,438,360 |
11,442,885 |
RGD:6480464 |
CTD |
| G |
Ftsjd2 |
FtsJ methyltransferase domain containing 2 |
|
affects expression |
ISO |
20 |
7,970,034 |
8,014,387 |
RGD:6480464 |
CTD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
affects expression |
ISO |
5 |
154,703,722 |
154,720,971 |
RGD:6480464 |
CTD |
| G |
Fuca2 |
fucosidase, alpha-L- 2, plasma |
|
affects expression |
ISO |
1 |
8,289,580 |
8,304,369 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
increases expression |
EXP |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
affects expression |
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
affects expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
affects expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
decreases expression |
EXP |
15 |
51,279,770 |
51,371,053 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
affects expression |
ISO |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
increases response to substance |
ISO |
4 |
84,135,530 |
84,148,503 |
RGD:6480464 |
CTD |
| G |
Gins2 |
GINS complex subunit 2 (Psf2 homolog) |
|
affects expression |
ISO |
19 |
50,915,108 |
50,927,668 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
increases expression |
EXP |
10 |
84,732,705 |
84,740,801 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja4 |
gap junction protein, alpha 4 |
|
affects expression |
ISO |
5 |
146,755,061 |
146,757,594 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
decreases expression |
EXP |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
affects expression |
EXP |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Gla |
galactosidase, alpha |
|
affects expression |
ISO |
X |
122,044,703 |
122,056,327 |
RGD:6480464 |
CTD |
| G |
Glipr1 |
GLI pathogenesis-related 1 |
|
affects expression |
ISO |
7 |
51,081,712 |
51,092,707 |
RGD:6480464 |
CTD |
| G |
Glipr2 |
GLI pathogenesis-related 2 |
|
affects expression |
ISO |
5 |
60,419,965 |
60,439,957 |
RGD:6480464 |
CTD |
| G |
Glis2 |
GLIS family zinc finger 2 |
|
affects expression |
ISO |
10 |
11,080,702 |
11,100,905 |
RGD:6480464 |
CTD |
| G |
Glt8d2 |
glycosyltransferase 8 domain containing 2 |
|
affects expression |
ISO |
7 |
23,265,829 |
23,299,748 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
increases expression |
EXP |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gm2a |
GM2 ganglioside activator |
|
affects expression |
ISO |
10 |
40,502,175 |
40,514,708 |
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
affects expression |
ISO |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gmppb |
GDP-mannose pyrophosphorylase B |
|
affects expression |
ISO |
8 |
113,317,165 |
113,346,646 |
RGD:6480464 |
CTD |
| G |
Gmpr |
guanosine monophosphate reductase |
|
affects expression |
ISO |
17 |
25,147,730 |
25,185,385 |
RGD:6480464 |
CTD |
| G |
Gmpr |
guanosine monophosphate reductase |
|
decreases expression |
EXP |
17 |
25,147,730 |
25,185,385 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
affects expression |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
affects expression |
ISO |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
affects expression |
ISO |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnb5 |
guanine nucleotide binding protein (G protein), beta 5 |
|
affects expression |
ISO |
8 |
80,128,787 |
80,169,629 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
decreases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
affects expression |
EXP |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases activity |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gp1bb |
glycoprotein Ib (platelet), beta polypeptide |
|
affects expression |
ISO |
11 |
84,369,795 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
affects expression |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
multiple interactions |
ISO |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
increases expression |
ISO |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpc4 |
glypican 4 |
|
affects expression |
ISO |
X |
138,966,579 |
139,077,074 |
RGD:6480464 |
CTD |
| G |
Gphn |
gephyrin |
|
affects expression |
ISO |
6 |
100,833,004 |
101,302,957 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
increases expression |
EXP |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
affects expression |
ISO |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpr1 |
G protein-coupled receptor 1 |
|
increases expression |
EXP |
9 |
61,837,807 |
61,838,868 |
RGD:6480464 |
CTD |
| G |
Gpr126 |
G protein-coupled receptor 126 |
|
affects expression |
ISO |
1 |
9,290,306 |
9,402,175 |
RGD:6480464 |
CTD |
| G |
Gpr155 |
G protein-coupled receptor 155 |
|
affects expression |
ISO |
3 |
55,846,337 |
55,900,086 |
RGD:6480464 |
CTD |
| G |
Gpr176 |
G protein-coupled receptor 176 |
|
affects expression |
ISO |
3 |
104,699,853 |
104,801,217 |
RGD:6480464 |
CTD |
| G |
Gpr27 |
G protein-coupled receptor 27 |
|
affects expression |
ISO |
4 |
134,541,534 |
134,542,667 |
RGD:6480464 |
CTD |
| G |
Gpr37 |
G protein-coupled receptor 37 |
|
increases expression |
EXP |
4 |
52,166,918 |
52,188,983 |
RGD:6480464 |
CTD |
| G |
Gpr85 |
G protein-coupled receptor 85 |
|
affects expression |
ISO |
4 |
39,296,054 |
39,299,722 |
RGD:6480464 |
CTD |
| G |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
|
affects expression |
ISO |
1 |
177,205,905 |
177,230,442 |
RGD:6480464 |
CTD |
| G |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
|
decreases expression |
EXP |
1 |
177,205,905 |
177,230,442 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases secretion |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
increases activity |
ISO |
19 |
22,884,586 |
22,915,553 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
increases expression |
ISO |
19 |
22,884,586 |
22,915,553 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gyg1 |
glycogenin 1 |
|
decreases expression |
EXP |
2 |
105,264,657 |
105,307,070 |
RGD:6480464 |
CTD |
| G |
H2afj |
H2A histone family, member J |
|
decreases expression |
ISO |
4 |
173,818,670 |
173,819,154 |
RGD:6480464 |
CTD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
affects expression |
EXP |
6 |
26,173,798 |
26,191,433 |
RGD:6480464 |
CTD |
| G |
Hadhb |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
affects expression |
EXP |
6 |
26,139,397 |
26,173,428 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
decreases expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
increases expression |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
affects expression |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hcfc1r1 |
host cell factor C1 regulator 1 (XPO1-dependent) |
|
affects expression |
ISO |
10 |
12,938,469 |
12,940,104 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
affects expression |
ISO |
2 |
179,981,346 |
179,991,892 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
affects expression |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Helz |
helicase with zinc finger |
|
affects expression |
ISO |
10 |
96,952,234 |
97,091,028 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
affects expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
affects expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44-like |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
affects expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
increases expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
increases expression |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
affects expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
increases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
|
increases expression |
ISO |
3 |
105,322,270 |
105,341,927 |
RGD:6480464 |
CTD |
| G |
Ldb3 |
LIM domain binding 3 |
|
affects expression |
ISO |
16 |
10,221,362 |
10,247,798 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
|
affects expression |
ISO |
5 |
128,905,612 |
128,975,702 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
decreases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pragmin |
pragma of Rnd2 |
|
increases expression |
ISO |
16 |
59,780,251 |
59,833,359 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
increases expression |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
increases activity |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
increases expression |
EXP |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
RGD1359529 |
similar to chromosome 1 open reading frame 63 |
|
decreases expression |
ISO |
5 |
153,698,946 |
153,702,685 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
affects expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rps24 |
ribosomal protein S24 |
|
affects expression |
EXP |
16 |
43,766 |
48,353 |
RGD:6480464 |
CTD |
| G |
Rps29 |
ribosomal protein S29 |
|
affects expression |
EXP |
6 |
91,115,709 |
91,117,085 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
affects expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
|
decreases expression |
EXP |
1 |
29,930,908 |
29,973,686 |
RGD:6480464 |
CTD |
| G |
Smad7 |
SMAD family member 7 |
|
decreases expression |
EXP |
18 |
72,294,803 |
72,323,354 |
RGD:6480464 |
CTD |
| G |
Snrnp200 |
small nuclear ribonucleoprotein 200 (U5) |
|
decreases expression |
ISO |
3 |
114,708,628 |
114,738,549 |
RGD:6480464 |
CTD |
| G |
Spdl1 |
spindle apparatus coiled-coil protein 1 |
|
affects expression |
ISO |
10 |
19,684,827 |
19,709,881 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases activity |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnxb |
tenascin XB |
|
affects expression |
ISO |
20 |
4,133,875 |
4,178,049 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
affects expression |
ISO |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
Term paths to the root
|